Joseph S Dillon

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Drug Administration

Radiation Therapy

Top Venues

Future oncology (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of gastrointestinal cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph S Dillon, David Bushnell, Douglas E Laux
High-specific-activity 131iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma. Future oncology (London, England) 17 (10) (2021)
Abhishek Jha, David Taïeb, Jorge A Carrasquillo, Daniel A Pryma, Mayank Patel, Corina Millo, Wouter W de Herder, Jaydira Del Rivero, Joakim Crona, Barry L Shulkin, Irene Virgolini, Helen X Chen, Bhagwant R Mittal, Sandip Basu, Joseph S Dillon, Thomas A Hope, Carina Mari Aparici, Andrei H Iagaru, Rodney John Hicks, Anca M Avram, Jonathan R Strosberg, Ali Cahid Civelek, Frank I Lin, Neeta Pandit-Taskar, Karel Pacak
High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Joseph S Dillon, Matthew H Kulke, Dieter Hörsch, Lowell B Anthony, Richard R P Warner, Emily Bergsland, Staffan Welin, Thomas M O'Dorisio, Pamela L Kunz, Chad McKee, Pablo Lapuerta, Phillip Banks, Marianne Pavel
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome. Journal of gastrointestinal cancer 52 (1) (2021)